HMH -OCEAN UNIVERSITY MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.5M
- Transactions
- 172
- Companies
- 15
- Average per transaction
- $14,778
Who reported the payments
| Janssen Research & Development, LLC | $902,958 |
| Novartis | $574,428 |
| E.r. Squibb & Sons, L.L.C. | $566,381 |
| Karyopharm Therapeutics Inc. | $278,740 |
| CSL Behring | $74,016 |
| Astellas Pharma Global Development | $35,000 |
| Mirati Therapeutics, Inc. | $34,972 |
| Regeneron | $33,446 |
| Edwards Lifesciences | $24,828 |
| Olympus America Inc. | $9,304 |
| ADC Therapeutics America, Inc. | $5,759 |
| Bayer | $700 |
| Cashflow Solutions, LLC | $653 |
| Stryker | $629 |
| Cardiovascular Systems Inc. | $39 |